Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1997
Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET
E Q Chen, W J MacIntyre, R T Go, et al.
European Journal of Nuclear Medicine
|
August 1, 1996
Measurement of cardiac output with first-pass determination during rubidium-82 PET myocardial perfusion imaging
E Q Chen, W J MacIntyre, F M Fouad, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 1, 1996
Outcome of temporal lobe epilepsy surgery predicted by statistical parametric PET imaging
C Y Wong, E B Geller, E Q Chen, et al.
Journal of Viral Hepatitis
|
October 31, 2017
Efficacy and safety of three adefovir-based combination therapies in HBeAg-positive chronic hepatitis B patients with suboptimal response to adefovir monotherapy
M-L Wang, E-Q Chen, D-M Zhang, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
March 1, 1996
The incidence of scintigraphically viable and nonviable tissue by rubidium-82 and fluorine-18-fluorodeoxyglucose positron emission tomographic imaging in patients with prior infarction and left ventricular dysfunction
R T Go, W J MacIntyre, S A Cook, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
November 11, 2024
[Efficacy evaluation of extending or switching to tenofovir amibufenamide in patients with chronic hepatitis B: a phase Ⅲ randomized controlled study]
Z H Liu, Q L Jin, Y X Zhang, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
November 11, 2024
[Safety profile of tenofovir amibufenamide therapy extension or switching in patients with chronic hepatitis B: a phase Ⅲ multicenter, randomized controlled trial]
Z H Liu, Q L Jin, Y X Zhang, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1997
Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET
E Q Chen, W J MacIntyre, R T Go, et al.
European Journal of Nuclear Medicine
|
August 1, 1996
Measurement of cardiac output with first-pass determination during rubidium-82 PET myocardial perfusion imaging
E Q Chen, W J MacIntyre, F M Fouad, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 1, 1996
Outcome of temporal lobe epilepsy surgery predicted by statistical parametric PET imaging
C Y Wong, E B Geller, E Q Chen, et al.
Journal of Viral Hepatitis
|
October 31, 2017
Efficacy and safety of three adefovir-based combination therapies in HBeAg-positive chronic hepatitis B patients with suboptimal response to adefovir monotherapy
M-L Wang, E-Q Chen, D-M Zhang, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
March 1, 1996
The incidence of scintigraphically viable and nonviable tissue by rubidium-82 and fluorine-18-fluorodeoxyglucose positron emission tomographic imaging in patients with prior infarction and left ventricular dysfunction
R T Go, W J MacIntyre, S A Cook, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
November 11, 2024
[Efficacy evaluation of extending or switching to tenofovir amibufenamide in patients with chronic hepatitis B: a phase Ⅲ randomized controlled study]
Z H Liu, Q L Jin, Y X Zhang, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|
November 11, 2024
[Safety profile of tenofovir amibufenamide therapy extension or switching in patients with chronic hepatitis B: a phase Ⅲ multicenter, randomized controlled trial]
Z H Liu, Q L Jin, Y X Zhang, et al.
Page
of 3